Mannatech closed at $8.64 on Nov 4, down 0.06%, 12.2% below its 52-week closing high. Volume of 28.0K shares was 0.77× its 20-day average (below normal).
Split-adjusted performance: +10.9% over one month, +77.0% over six months.
In the quarter ended Jun 30, 2026, revenue was $26.65M, up 3.8% from a year earlier, with a net margin of 3.8%.
Short interest was 11.6K shares at the Oct 15 settlement, down 10.1% from the prior report (1.8% of float, 1.0 days to cover).
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness.
What is MTEX's market cap?
$16.67M, based on the Nov 4 close of $8.64.
Does Mannatech pay a dividend?
No regular cash dividend has been paid in the last year.
How much of MTEX is sold short?
11.6K shares, 1.8% of float, as of Oct 15, 2026.
What sector is MTEX in?
Healthcare, in the Pharmaceuticals industry.
About Mannatech
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.
HQ: Flower Mound, TX170 employeesListed Feb 16, 1999mannatech.com
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
